by [email protected] | Nov 2, 2020 | Gastrointestinal, immunology, Publication
Abstract Authors: David T Rubin, Jenny Griffith, Qisu Zhang, Zsolt Hepp, Allison Keshishian Background: Although there is evidence that anti-tumor necrosis factor (TNF) utilization earlier in the inflammatory bowel disease (IBD) course and before the...
by [email protected] | Oct 16, 2020 | Gastrointestinal, immunology, Publication
Abstract Authors: Chen G, Lissoos T, Dieyi C, Null KD Background Clinical indices to characterize the severity of inflammatory bowel disease (IBD) are widely used in clinical trials and real-world practice. However, there are few validated instruments for assessing...
by [email protected] | Oct 16, 2020 | Gastrointestinal, immunology, Publication
Authors: Camilo Obando, Zhijie Ding, Erik Muser, Neel Vaidya, Wenqin Qiang, Xiaoxi Sun, Huiqi Wang, Rajesh Mallampati, and Lin Xie Abstract Introduction: Crohn’s disease (CD) is a chronic inflammatory disease of the gastrointestinal tract. This real-world study...
by [email protected] | May 19, 2019 | Dermatological, immunology, Publication
Abstract Authors: Lee S, Xie L, Wang Y, Vaidya N, Baser O. Background: Psoriasis is a chronic, hyper-proliferative dermatological condition associated with joint symptoms known as psoriatic arthritis (PsA). In a 2013 review, the total economic burden of PsA was...
by [email protected] | May 16, 2019 | immunology, Publication
Abstract Authors: Yazici Y, Xie L, Ogbomo A, Ellis L, Goyal K, Teeple A, Simsek I. Purpose: This study compared treatment patterns of Turkish patients with a diagnosis of rheumatoid arthritis (RA) who were treated with innovator Remicade (infliximab [IFX]) and either...
by [email protected] | May 15, 2019 | immunology
Abstract Authors: Yazici Y, Xie L, Ogbomo A, Ellis L, Goyal K, Teeple A, Mutlu E, Simsek I. Purpose: Biosimilar IFX (CT-P13) received marketing approval in Turkey for treatment of rheumatologic diseases, including ankylosing spondylitis, psoriatic arthritis,...
